Avera Heart Hospital in Sioux Falls broke ground on a $21.5 million, three-story expansion, with diagnostic imaging and ...

At eight years old, I had my third open-heart surgery — this time, to “tune up” my Fontan and implant my first pacemaker.

A 41-year-old Singaporean woman has given birth to a healthy baby girl after undergoing a rare, high-risk fetal heart surgery ...

The cardiovascular repair and reconstruction devices market offers vast opportunities with advancements in minimally invasive ...

Total Revenue -- $86,000 was recognized in the third quarter from initial sales of nPulse Capital and Vibrance disposables ...

Austin physicians are trying new ways to treat chronic heart conditions. Five cardiologists at Heart Hospital of Austin are ...

In the treatment of larger narrowed blood vessels, drug-coated balloon catheters have been shown to deliver lasting and ...

The Central Chest Institute of Thailand (CCIT) in Nonthaburi has adopted the Tavi procedure to treat aortic valve stenosis, a ...

Imricor Medical Systems, Inc. ( Company or Imricor) ( ASX: IMR ), together with Amsterdam University Medical Centre ...

Get the latest on Pulse Biosciences’ Q3 2025 earnings: commercial growth, FDA progress, and clinical trial updates in soft tissue and cardiac therapies.

Infants born before 24 weeks have survival chances below 50 percent, and about 40 percent of those who survive face long-term complications. By 24 weeks, however, the survival rate improves ...